Press Releases Latest Oct 13, 2021 Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update Press Releases Year None202120202019201820172016201520142013 Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population Jul 30, 2020 Theratechnologies To Present At The Canaccord Genuity 40th Annual Growth Conference On August 12, 2020 Jul 23, 2020 Theratechnologies Reports That Tesamorelin Improves Liver Health Jul 16, 2020 Announcements In Conjunction With Theratechnologies Annual Meeting Jul 15, 2020 Theratechnologies Announces Financial Results For The Second Quarter Of Fiscal 2020 Jul 07, 2020 Theratechnologies Confirms Bioequivalence Of New Tesamorelin Formulation Jul 06, 2020 Theratechnologies Announces Ibalizumab Inhibits HIV-2 In Vitro Jun 26, 2020 Theratechnologies To Announce Financial Results For Second Quarter 2020 Jun 22, 2020 New Data Show Theratechnologies’ SORT1+ Technology Is Effective In Many Treatment-Resistant Cancers May 15, 2020 Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers First page « Previous page ‹ … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page › Last page » Displaying 51 - 60 of 262
Oct 13, 2021 Theratechnologies Reports Financial Results for the Third Quarter of Fiscal 2021 and Provides Business Update
Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population
Jul 30, 2020 Theratechnologies To Present At The Canaccord Genuity 40th Annual Growth Conference On August 12, 2020
Jun 22, 2020 New Data Show Theratechnologies’ SORT1+ Technology Is Effective In Many Treatment-Resistant Cancers
May 15, 2020 Theratechnologies Unveils New Positive Data For Its Investigational Peptide-Drug Conjugates Targeting Sortilin Positive Cancers
